Company: EHC
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000785161-25-000009
Chunk: 60

Company: Encompass Health Corp
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 60
---
 31, 2024Fair ValueQuoted Prices in Active Markets for Identical Assets(Level 1)Significant Other Observable Inputs(Level 2)Significant Unobservable Inputs(Level 3)Valuation Technique (1)Equity securities$130.9 $4.2 $126.7 $— MRedeemable noncontrolling interests56.5 — — 56.5 IAs of December 31, 2023     Equity securities$126.2 $4.0 $122.2 $— MRedeemable noncontrolling interests42.0 — — 42.0 I(1)The two valuation techniques are: market approach (M) and income approach (I).There are assets and liabilities that are not required to be measured at fair value on a recurring basis. However, these assets may be recorded at fair value as a result of impairment charges or other adjustments made to the carrying value of the applicable assets. During the years ended December 31, 2024, 2023, and 2022, we did not record any material gains or losses related to these assets.

F-35

Encompass Health Corporation and SubsidiariesNotes to Consolidated Financial Statements

As discussed in Note 1, Summary of Significant Accounting Policies, “Fair Value Measurements,” the carrying value equals fair value for our financial instruments that are not included in the table below and are classified as current in our consolidated balance sheets. The carrying amounts and estimated fair values for our other financial instruments are presented in the following table (in millions): As of December 31, 2024As of December 31, 2023 Carrying AmountEstimated Fair ValueCarrying AmountEstimated Fair ValueLong-term debt:    Advances under revolving credit facility$20.0 $20.0 $— $— 5.75% Senior Notes due 202599.8 99.7 348.5 349.3 4.50% Senior Notes due 2028788.4 772.3 785.0 763.6 4.75% Senior Notes due 2030784.2 759.0 781.5 755.0 4.625% Senior Notes due 2031392.5 369.9 391.5 369.4 Other notes payable94.5 94.5 66.